Abstract
Neoadjuvant ‘Full Dose’ oxaliplatin/capecitabine/radiotherapy for MRI selected ‘very’ high risk rectal cancers with gross circumferential resection margin (CRM) involvement
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have